R&D Systems™ Recombinant Human IL-15R alpha Fc Chimera (HEK293)

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 7194IR050

Catalog No. 7194IR050

Description

The Recombinant Human IL-15R alpha Fc Chimera (HEK293) is derived from HEK293. The Recombinant Human IL-15R alpha Fc Chimera (HEK293) has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Molecular Weight (g/mol): 45 kDa (monomer)
• Quantity: 50μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: CD215, CD215 antigen, IL15 R alpha, IL-15 R alpha, IL-15 receptor subunit alpha, IL15RA, IL-15RA, IL-15R-alpha, interleukin 15 receptor, alpha, interleukin-15 receptor subunit alpha, MGC104179
• Recombinant: Recombinant

• Gene ID (Entrez): 3601
• Name: IL-15R alpha
• Source: Human embryonic kidney cell,HEK293-derived human IL-15 R alpha protein, (N-terminus) Human IL-15 R alpha (Met1-Thr205) Accession &Num; Q13261 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Structural Form: Disulfide-linked homodimer
• Conjugate: Unconjugated
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.